GT Medical Technologies develops medical technologies to improve outcomes for patients with brain tumors.
GT Medical Technologies has raised $100.0M in total funding. The most recent round was Series E. The last funding was announced in June 2026.
GT Medical Technologies's investors include FemHealth Ventures, MVM Life Science Partners, Viking Global Investors, MedTech Venture Partners, Gilde Healthcare.
GT Medical Technologies is headquartered in Tempe, United States.
GT Medical Technologies develops medical technologies to improve outcomes for patients with brain tumors.
GT Medical Technologies is at the Series E stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"GT Medical Technologies — Funding & Investors." VCBacked, June 9, 2026, https://www.vcbacked.co/company/gt-medical-technologies-tempe-2. Accessed October 21, 2026.
VCBacked. (2026). GT Medical Technologies — Funding & Investors. Retrieved October 21, 2026, from https://www.vcbacked.co/company/gt-medical-technologies-tempe-2
{{cite web |title=GT Medical Technologies — Funding & Investors |url=https://www.vcbacked.co/company/gt-medical-technologies-tempe-2 |website=VCBacked |access-date=October 21, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated